FDA approves new drug for treatment of type 2 diabetes
The U.S “Food and Drug and Administration” have proclaimed the approval of a new drug that goes by the name Jardiance, to aid treat type 2 diabetes. In order to improve the control of the blood sugar levels, an adult is not only expected to take the tablets but also combine exercise and diet. Type 2 diabetes is characterized by high blood glucose known as hyperglycemia. This is as an outcome of the body being incapable to produce enough insulin. This is called insulin resistance.
High levels of blood sugar can lead serious long-term and short-term health issues such as kidney and nerve impairment, heart disease, and blindness. (Liakos, 2014, p. 85). Before the introduction of Jardiance, type 2 diabetes was treated using glimepiride, sitagliptin, metformin, insulin and pioglitazone.
Made by Boehringer Pharmaceuticals, Jardiance belongs to the class of diabetes medications referred to as “Sodium glucose inhibitors”. The drugs work by halting blood glucose or sugar from being reabsorbed by the kidneys.
…………………………………………middle of paper………………………………..
In conclusion, Jardiance can be used alone or even added to the existing treatment schedule in order to standardize blood sugar levels in the general management of diabetes. It is also suggested that Jardiance should be used along with lifestyle alterations such as consistent exercises and having a healthy diet. Taking Jardiance tablets with lifestyle modification can improve blood sugar supervision for patients suffering type 2 diabetes.
Walker, T. (2014). FDA approves empagliflozin tablets to treat type 2 diabetes.
Dey, L., & Attele, A. S. (2011). Type 2 diabetes 231.
Are you ready to order a custom essay from us ? Place your order with us today.